NEW YORK and NOIDA, India, Dec 02, 2024—HCLTech, a leading global technology company, has announced that it has attained the AWS Life Sciences Competency status. This recognition highlights HCLTech’s advanced technical proficiency and capabilities in assisting enterprises to foster innovation, elevate patient care experiences, enhance health outcomes and lower healthcare costs through its life sciences services and solutions on AWS Cloud.
“We have been a trusted transformation partner for leading and emerging life sciences enterprises for over two decades now. The AWS Life Sciences Competency emphasizes our commitment to helping enterprises leverage AWS Cloud for faster innovation, improved efficiencies and advanced GenAI capabilities, guided by AWS's architectural and operational best practices,” said Prabhakar Appana, Senior Vice President and Head of AWS Business Unit, HCLTech.
HCLTech has now achieved 34 recognitions under the AWS Competency and Service Delivery Programs, including the latest AWS Life Sciences Competency. This ensures that HCLTech's clients benefit from comprehensive, data-driven digital transformation, driving efficiency, innovation and growth across various sectors.
HCLTech's AWS solutions, including Advanced Clinical Trials and Diagnosis Solutions, CARE, and others, have empowered life sciences enterprises to enhance their capabilities in drug discovery, development and manufacturing, and bringing therapeutics to market.
Learn more about HCLTech AWS relationship: https://www.hcltech.com/aws
About HCLTech
HCLTech is a global technology company, home to more than 218,000 people across 60 countries, delivering industry-leading capabilities centered around digital, engineering, cloud and AI, powered by a broad portfolio of technology services and products. We work with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, Technology and Services, Telecom and Media, Retail and CPG and Public Services. Consolidated revenues as of 12 months ending September 2024 totaled $13.7 billion. To learn how we can supercharge progress for you, visit hcltech.com.
For further details, please contact:
Meredith Bucaro, Americas
meredith-bucaro@hcltech.com
Elka Ghudial, EMEA
elka.ghudial@hcltech.com
James Galvin, ANZ
james.galvin@hcltech.com
Nitin Shukla, India
nitin-shukla@hcltech.com